Protara Therapeutics (TARA) Insider Trading & Ownership $3.72 -0.23 (-5.82%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$3.66 -0.07 (-1.75%) As of 02/21/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Protara Therapeutics (NASDAQ:TARA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$891,116.44 Get TARA Insider Trade Alerts Want to know when executives and insiders are buying or selling Protara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TARA Insider Buying and Selling by Quarter Protara Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/11/2024Opaleye Management Inc.Major ShareholderSell32,600$1.71$55,746.00 9/9/2024Opaleye Management Inc.Major ShareholderSell36,492$1.89$68,969.88 7/16/2024Opaleye Management Inc.Major ShareholderSell11,396$2.44$27,806.24 7/11/2024Opaleye Management Inc.Major ShareholderSell47,993$2.40$115,183.20 7/9/2024Opaleye Management Inc.Major ShareholderSell8,497$2.21$18,778.37 7/1/2024Opaleye Management Inc.Major ShareholderSell8,288$2.12$17,570.56 6/27/2024Opaleye Management Inc.Major ShareholderSell46,574$2.26$105,257.24 6/25/2024Opaleye Management Inc.Major ShareholderSell12,725$2.26$28,758.50 5/30/2024Opaleye Management Inc.Major ShareholderSell9,230$2.94$27,136.20 5/21/2024Opaleye Management Inc.Major ShareholderSell33,000$3.06$100,980.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/17/2024Opaleye Management Inc.Major ShareholderSell70,885$3.25$230,376.25 5/9/2024Opaleye Management Inc.Major ShareholderSell30,600$3.09$94,554.00 (Data available from 1/1/2013 forward) TARA Insider Trading Activity - Frequently Asked Questions Who is on Protara Therapeutics's Insider Roster? The list of insiders at Protara Therapeutics includes Jesse Shefferman, Luke M Beshar, and Opaleye Management Inc.. Learn more on insiders at TARA. What percentage of Protara Therapeutics stock is owned by insiders? 12.50% of Protara Therapeutics stock is owned by insiders. Learn more on TARA's insider holdings. Which Protara Therapeutics insiders have been selling company stock? The following insider sold TARA shares in the last 24 months: Opaleye Management Inc. ($891,116.44). How much insider selling is happening at Protara Therapeutics? Insiders have sold a total of 348,280 Protara Therapeutics shares in the last 24 months for a total of $891,116.44 sold. Protara Therapeutics Key ExecutivesMr. Jesse Shefferman (Age 52)Co-Founder, CEO, President & Director Compensation: $1.11MDr. Jacqueline Zummo M.B.A. (Age 43)M.P.H., Ph.D., Co-Founder, Senior VP & Chief Scientific Operations Officer Compensation: $743.68kDr. Jathin Bandari M.D. (Age 36)Executive Officer Compensation: $687.86kMr. Patrick Fabbio M.B.A. (Age 56)Chief Financial Officer Ms. Hannah Fry (Age 33)VP, Principal Accounting Officer & Controller Ms. Justine O'MalleySenior Vice President of Investor Relations & Corporate AffairsMs. Mary J. GrendellGeneral Counsel & Corporate Secretary More Insider Trading Tools from MarketBeat Related Companies FHTX Insider Selling TSHA Insider Selling CYRX Insider Selling ANNX Insider Selling CRVS Insider Selling TRVI Insider Selling CMPS Insider Selling AQST Insider Selling GOSS Insider Selling CADL Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:TARA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
